|
| Own Slots | ||
|---|---|---|
| Slot Name | Value | |
 |
Alternatives | |
|
CanImprove | |
|
CautionWithMedicationsUsed | Norepinephrine |
|
Comment | |
|
Contraindication | |
|
CouldBeRelatedTo | |
|
Cui | C0013030 |
|
Definition | One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from tyrosine and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. (MeSH) |
|
DespiteReceivingTreatment | |
|
DoNotUseWithMedicationGroup | |
|
EspeciallyEffectiveAgainst | |
|
Improves | |
|
Incrementsmgday | |
|
InitiatingDose | |
|
MaintenanceDose | (infusion): < 3 ug/kg/min renal effect (beta+); 3-5 ug/kg/min inotropic (beta+); >5 ug/kg/min (beta+), vasopressor(alfa+) |
|
MaximumRecommendedDailyDose | |
|
MeanDailyDose | |
|
RelevantSignOrSymptom | |
|
SideEffect | |
|
Synonyms | |
|
TargetDose | |
|
TitrationPeriod | |
|
TreatmentStatus | |
|
Treats | |
|
UMLSSynonyms | |
|
UsedTogetherWithMedication | |
|
UsedWithMedicationGroup | |
|
UseWhenExistsIntoleranceOf | |
|
UseWithTest |